Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.

Muntner P, Levitan EB, Brown TM, Sharma P, Zhao H, Bittner V, Glasser S, Kilgore M, Yun H, Woolley JM, Farkouh ME, Rosenson RS.

Am J Cardiol. 2013 Sep 1;112(5):664-70. doi: 10.1016/j.amjcard.2013.04.041. Epub 2013 May 29.

2.

Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.

Lee YH, Lee SG, Lee MH, Kim JH, Lee BW, Kang ES, Lee HC, Cha BS.

J Am Heart Assoc. 2014 Feb 26;3(1):e000650. doi: 10.1161/JAHA.113.000650. Erratum in: J Am Heart Assoc. 2015 Oct;4(10):e001934.

3.

Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.

Hyre AD, Muntner P, Menke A, Raggi P, He J.

Ann Epidemiol. 2007 Jul;17(7):548-55. Epub 2007 Mar 28.

PMID:
17395483
4.

Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):109-14.

5.

Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.

Muntner P, DeSalvo KB, Wildman RP, Raggi P, He J, Whelton PK.

Am J Epidemiol. 2006 May 15;163(10):913-20. Epub 2006 Apr 5.

PMID:
16597707
6.

Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004.

Upadhyay UD, Waddell EN, Young S, Kerker BD, Berger M, Matte T, Angell SY.

Prev Chronic Dis. 2010 May;7(3):A61. Epub 2010 Apr 15.

7.

Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006.

Kuklina EV, Yoon PW, Keenan NL.

JAMA. 2009 Nov 18;302(19):2104-10. doi: 10.1001/jama.2009.1672.

PMID:
19920234
8.

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults.

Hoerger TJ, Bala MV, Bray JW, Wilcosky TC, LaRosa J.

Am J Cardiol. 1998 Jul 1;82(1):61-5.

PMID:
9671010
9.

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

Sempos CT, Cleeman JI, Carroll MD, Johnson CL, Bachorik PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, et al.

JAMA. 1993 Jun 16;269(23):3009-14.

PMID:
8501843
10.

Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China.

He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J, Whelton PK; InterASIA Collaborative Group.

Circulation. 2004 Jul 27;110(4):405-11. Epub 2004 Jul 6.

11.

Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.

Muntner P, Gu D, Reynolds RF, Wu X, Chen J, Whelton PK, He J.

Am J Cardiol. 2005 Nov 1;96(9):1260-5. Epub 2005 Sep 6.

PMID:
16253594
12.

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

Mann D, Reynolds K, Smith D, Muntner P.

Ann Pharmacother. 2008 Sep;42(9):1208-15. doi: 10.1345/aph.1L181. Epub 2008 Jul 22.

PMID:
18648016
13.

National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.

Cullen MW, Stein JH, Gangnon R, McBride PE, Keevil JG.

Am Heart J. 2008 Aug;156(2):284-91. doi: 10.1016/j.ahj.2008.03.004. Epub 2008 Jun 4.

PMID:
18657658
14.

Trends in serum lipids and lipoproteins of adults, 1960-2002.

Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL.

JAMA. 2005 Oct 12;294(14):1773-81.

PMID:
16219880
15.

Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.

Foster MC, Rawlings AM, Marrett E, Neff D, Grams ME, Kasiske BL, Willis K, Inker LA, Coresh J, Selvin E.

Am J Kidney Dis. 2014 May;63(5):753-60. doi: 10.1053/j.ajkd.2013.11.014. Epub 2013 Dec 25.

17.

Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

Lotufo PA, Santos RD, Figueiredo RM, Pereira AC, Mill JG, Alvim SM, Fonseca MJ, Almeida MC, Molina MC, Chor D, Schmidt MI, Ribeiro AL, Duncan BB, Bensenor IM.

J Clin Lipidol. 2016 May-Jun;10(3):568-76. doi: 10.1016/j.jacl.2015.12.029. Epub 2016 Jan 14.

PMID:
27206944
18.

Trends in lipids and lipoproteins in US adults, 1988-2010.

Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME.

JAMA. 2012 Oct 17;308(15):1545-54. doi: 10.1001/jama.2012.13260.

PMID:
23073951
19.

30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006.

Cohen JD, Cziraky MJ, Cai Q, Wallace A, Wasser T, Crouse JR, Jacobson TA.

Am J Cardiol. 2010 Oct 1;106(7):969-75. doi: 10.1016/j.amjcard.2010.05.030. Epub 2010 Aug 11. Erratum in: Am J Cardiol. 2010 Dec 15;106(12):1826.

PMID:
20854959
20.

Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.

Tóth PP, Potter D, Ming EE.

J Clin Lipidol. 2012 Jul-Aug;6(4):325-30. doi: 10.1016/j.jacl.2012.05.002. Epub 2012 May 22.

PMID:
22836069

Supplemental Content

Support Center